Skip to Primary Navigation

FDA launches program to bolster domestic drug manufacturing

A photo of a sign in front of the FDA headquarters.
Photo: Sarah Silbiger/Getty Images

The PreCheck program aims to make it significantly less onerous to set up domestic manufacturing plants provided they align with US national priorities.

The US Food and Drug Administration (FDA) officially launched its FDA PreCheck pilot program and is now accepting requests from drug manufacturers.

Initially announced in August, the FDA PreCheck program is designed to make it significantly less onerous to establish domestic manufacturing plants by increasing regulatory predictability, facilitating the construction

Subscribe for free to continue reading

Read more articles like this one with our free plan, or get our Premium plan for access to all content – including our 5,000+ article archive, exclusive interviews, podcasts, and more.

Already have an account? Sign in